Diagnostic protein biomarkers for severe, moderate and mild traumatic brain injury

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 8029, Issue , 2011, Pages

  Streeter, Jackson ^a   Hayes, Ronald L ^a   Wang, Kevin K W ^a  

^a BANYAN BIOMARKERS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT PATIENTS; BIOMARKER ASSESSMENT; BLOOD SAMPLES; BREAKDOWN PRODUCTS; CALPAINS; CLINICAL STUDY; COMBAT ENVIRONMENTS; DIAGNOSTIC ASSAYS; FEASIBILITY STUDIES; GLASGOW COMA SCALE; GLIAL FIBRILLARY ACIDIC PROTEINS; HANDHELDS; MILD TRAUMATIC BRAIN INJURIES; NON-INVASIVE DIAGNOSTICS; PILOT STUDIES; SERUM LEVELS; SYSTEMS BIOLOGY; TRAUMATIC BRAIN INJURIES; UBIQUITIN;

ASSAYS; BIOMETRICS; BLOOD; BRAIN; DIAGNOSIS; ENVIRONMENTAL ENGINEERING; TECHNOLOGY;

BIOMARKERS;

EID: 79959831407     PISSN: 0277786X     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.885615     Document Type: Conference Paper

References (77)

1. Hoffman SW, Shesko K, Harrison CR. Enhanced neurorehabilitation techniques in the DVBIC Assisted Living Pilot Project. NeuroRehabilitation. 26(3):257-69 (2010).
2. Jager TE, Weiss HB, Coben JH, Pepe PE. Traumatic brain injuries evaluated in U.S. emergency departments, 1992-1994. Acad Emerg Med ; 7 (2): 134-40 (2000)
3. [No authors] TBI State Demonstration Grants. J Head Trauma Rehabil. Feb;15(1):750-60. (2000)
4. Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A, Manley GT; Classification of traumatic brain injury for targeted therapies. Workshop Scientific Team and Advisory Panel Members. J Neurotrauma. Jul;25(7):719-38. (2008)
5. Wang, K. K. W., Ottens, A. K., Liu, M. C., Lewis, S. B., Meegan, C., Oli, M. W., Tortella, F. C. and Hayes, R. L. Proteomic identification of biomarkers of traumatic brain injury. Exp. Rev. Proteomics. 2, 603-614. (2005)
6. Jenkins LW, Peters GW, Dixon CE, Zhang X, Clark RS, Skinner JC, Marion DW, Adelson PD, Kochanek PM. Conventional and functional proteomics using large format two-dimensional gel electrophoresis 24 hours after controlled cortical impact in postnatal day 17 rats. J Neurotrauma. Jun;19(6):715-40. (2002)
7. Denslow N, Michel ME, Temple MD, Hsu CY, Saatman K, Hayes RL. Application of proteomics technology to the field of neurotrauma. J Neurotrauma. May;20(5):401-7. Review. (2003)
8. Kobeissy, F.H., Ottens, A.K., Zhang, Z.Q., Dave, J.R., Tortella F.C., Hayes, R.L. Wang, K.K.W. Differential proteomic analysis of traumatic brain injury biomarker study using CAX-PAGE/RPLCMSMS method. Mo. Cell. Proteomics 5, Oct;5(10):1887-1898. (2006)
9. Papa, L., Robinson, G. M.W. Oli, M.W., Robicsek, S.A., Gabrielli, A. , Robertson, C. S., Wang, K.K.W. Hayes, R.L. Use of Biomarkers for Diagnosis and Management of Traumatic Brain Injury Patients. Expert Opin. Med. Diagnostics, 2(8):1-9 (2008)
10. Chan D, Ng LL. Biomarkers in acute myocardial infarction. BMC Med. Jun 7;8:34. (2010)
11. Hochholzer W, Morrow DA, Giugliano RP. Novel biomarkers in cardiovascular disease: update 2010.Am Heart J. Oct;160(4):583-94. Review. (2010)
12. Singh V, Martinezclark P, Pascual M, Shaw ES, O'Neill WW. Cardiac biomarkers - the old and the new: a review. Coron Artery Dis. Jun;21(4):244-56. Review.(2010)
13. Velagaleti RS, Gona P, Larson MG, Wang TJ, Levy D, Benjamin EJ, Selhub J, Jacques PF, Meigs JB, Tofler GH, Vasan RS. Multimarker approach for the prediction of heart failure incidence in the community. Circulation. Oct 26;122(17):1700-6. Epub 2010 Oct 11. (2010)
14. Sherer M, Struchen MA, Yablon SA, Wang Y, Nick TG. Comparison of indices of traumatic brain injury severity: Glasgow Coma Scale, length of coma and post-traumatic amnesia. J Neurol Neurosurg Psychiatry. Jun;79(6):678-85. (2008)
15. Schaller B, Evangelopoulos DS, Müller C, Martinolli L, Pouljadoff MP, Zimmermann H, Exadaktylos AK. Do we really need 24-h observation for patients with minimal brain injury and small intracranial bleeding? The Bernese Trauma Unit Protocol. Emerg Med J. Jul;27(7):537-9. Epub 2010 Apr 1. (2010)
16. Levi L, Guilburd JN, Lemberger A, Soustiel JF, Feinsod M. Diffuse axonal injury: Analysis of 100 patients with radiological signs. Neurosurgery ; 27:429-432. (1990)
17. Kesler ea. APECT, MR and quantitative MR imaging: correlates with neuropsycholgical. Brain Injury ; 14:851-857. (2000)
18. Dula K, Mini R, van der Stelt PF, Lambrecht JT, Schneeberger P, Buser D. Hypothetical mortality risk associated with spiral computed tomography of the maxilla and mandible. Eur J Oral Sci ; 104:503-10. (1996)
19. Servadei F, Murray GD, Penny K, et al. The value of the "worst" computed tomographic scan in clinical studies of moderate and severe head injury. European Brain Injury Consortium. Neurosurgery ; 46:70-5; discussion 75-7. (2000)
20. Scaife ER, Rollins MD. Managing radiation risk in the evaluation of the pediatric trauma patient. Semin Pediatr Surg. Nov;19(4):252-6. Review.(2010)
21. Manley GT, Diaz-Arrastia R, Brophy M, Engel D, Goodman C, Gwinn K, Veenstra TD, Ling G, Ottens AK, Tortella F, Hayes RL. Common data elements for traumatic brain injury: recommendations from the biospecimens and biomarkers working group. Arch Phys Med Rehabil. Nov;91(11):1667-72. (2010)
22. Hellewell SC, Yan EB, Agyapomaa DA, Bye N, Morganti-Kossmann MC. Post-traumatic hypoxia exacerbates brain tissue damage: analysis of axonal injury and glial responses. J Neurotrauma. Nov;27(11):1997-2010. (2010)
23. Stein DM, Kufera JA, Lindell A, Murdock KR, Menaker J, Bochicchio GV, Aarabi B, Scalea TM. Association of CSF Biomarkers and Secondary Insults Following Severe Traumatic Brain Injury. Neurocrit Care. Jan 6. [Epub ahead of print] (2011)
24. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neruological Surgeons CDC study TBI management J. Neurotruma, , Vol. 24 Supplement 1. (2007)
25. Stocchetti N, Pagan F, Calappi E, Canavesi K, Beretta L, Citerio G, Cormio M, Colombo A. Inaccurate early assessment of neurological severity in head injury. J Neurotrauma. Sep;21(9):1131-40. (2004)
26. Marion DW, Carlier PM. Problems with initial Glasgow Coma Scale assessment caused by prehospital treatment of patients with head injuries: results of a national survey. J Trauma. Jan;36(1):89-95. (1994)
27. Livingston BM, Mackenzie SJ, MacKirdy FN, Howie JC. Should the pre-sedation Glasgow Coma Scale value be used when calculating Acute Physiology and Chronic Health Evaluation scores for sedated patients? Scottish Intensive Care Society Audit Group. Crit Care Med. Feb;28(2):389-94. (2000)
28. Lindenbaum GA, Carroll SF, Daskal I, Kapusnick R. Patterns of alcohol and drug abuse in an urban trauma center: the increasing role of cocaine abuse. J Trauma. Dec;29(12):1654-8. (1989)
29. Corrigan JD. Substance abuse as a mediating factor in outcome from traumatic brain injury. Arch Phys Med Rehabil. Apr;76(4):302-9. Review. (1995)
30. Vollmer DG, Dacey RG Jr. The management of mild and moderate head injuries. Neurosurg Clin N Am ; 2 (2): 437-55 (1991)
31. Yealy DM, Hogan DE. Imaging after head trauma. Who needs what? Emerg Med Clin North Am ; 9 (4): 707-17 (1991)
32. Kennedy RE, Livingston L, Marwitz JH, Gueck S, Kreutzer JS, Sander AM. Complicated mild traumatic brain injury on the inpatient rehabilitation unit: a multicenter analysis. J Head Trauma Rehabil. May-Jun;21(3):260-71. (2006)
33. Gautschi OP, Frey SP, Zellweger R. [Diagnosis and management of patients with mild traumatic brain injury - an update with recommendations and future perspectives]. Praxis Jan 17;96(3):53-8. (2007)
34. Centers for Disease Control and Prevention (CDC). Sports-related recurrent brain injuries - United States. MMWR Morb Mortal Wkly Rep. Mar 14;46(10):224-7. (1997)
35. Foley N, Marshall S, Pikul J, Salter K, Teasell R. Hypermetabolism following moderate to severe traumatic acute brain injury: a systematic review. J Neurotrauma. Dec;25(12):1415-31. Review. (2008)
36. Missler U, Wiesmann M, Friedrich C, Kaps M S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 28:1956-1960. (1997)
37. Ross SA, Cunningham RT, Johnston CF, Rowlands BJ Neuron-specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg 10:471-476. (1996)
38. Yamazaki Y, Yada K, Morii S, Kitahara T, Ohwada T Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury. Surg Neurol 43:267-270. (1995)
39. Raabe A, Grolms C, Seifert V Serum markers of brain damage and outcome prediction in patients after severe head injury. Br J Neurosurg 13:56-59. (1999)
40. Romner B, Ingebrigtsen T, Kongstad P, Borgesen SE Traumatic brain damage: serum S-100 protein measurements related to neuroradiological findings. J Neurotrauma 17:641-647. (2000)
41. Pelinka LE, Kroepfl A, Schmidhammer R, Krenn M, Buchinger W, Redl H, Raabe A Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J Trauma 57:1006-1012. (2004a)
42. Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma 21:1553-1561. (2004b)
43. Vos PE, Lamers KJ, Hendriks JC, van Haaren M, Beems T, Zimmerman C, van Geel W, de Reus H, Biert J, Verbeek MM Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 62:1303-1310. (2004)
44. Lumpkins KM, Bochicchio GV, Keledjian K, Simard JM, McCunn M, Scalea T Glial fibrillary acidic protein is highly correlated with brain injury. J Trauma 65:778-784. (2008)
45. Johnsson P, Blomquist S, Lührs C, Malmkvist G, Alling C, Solem JO, Ståhl E Neuronspecific enolase increases in plasma during and immediately after extracorporeal circulation. Ann Thorac Surg 69:750-4. (2000)
46. Pelinka LE, Szalay L, Jafarmadar M, Schmidhammer R, Redl H, Bahrami S Circulating S100B is increased after bilateral femur fracture without brain injury in the rat. Br J Anaesth. 91:595-7. (2003)
47. Pelinka LE, Harada N, Szalay L, Jafarmadar M, Redl H, Bahrami S Release of S100B differs during ischemia and reperfusion of the liver, the gut, and the kidney in rats. Shock. 21:72-6. (2004c)
48. Berger R. P., Adelson P. D., Pierce M. C., Dulani T., Cassidy L. D. and Kochanek P. M. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. J. Neurosurg 103(1 Suppl), 61-68. (2005)
49. Berger R. P., Beers S. R., Richichi R., Wiesman D. and Adelson P. D. Serum biomarker concentrations and outcome after pediatric traumatic brain injury." J. Neurotrauma 24, 1793-1801. (2007)
50. Pelinka, L. E., H. Hertz, W. Mauritz, N. Harada, M. Jafarmadar, M. Albrecht, H. Redl and S. Bahrami "Nonspecific increase of systemic neuron-specific enolase after trauma: clinical and experimental findings." Shock 24(2): 119-123.(2005)
51. Siman R, Noszek JC. Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron. Jun;1(4):279-87. (1988)
52. Pike, B. R., Flint, J., Dutta, S., Johnson, E., Wang K. K. W. and Hayes, R. L. Accumulation of non-erythroid αII-spectrin and calpain-cleaved αII-spectrin breakdown products in cerebrospinal fluid after TBI in rats. J. Neurochem. 78, 1297-1306.(2001)
53. Siman, R., McIntosh, T. K., Soltesz, K. M., Chen, Z., Neumar, R. W., & Roberts, V. L. Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiol. Dis., 16, 311-320. (2004)
54. Siman R, Zhang C, Roberts VL, Pitts-Kiefer A, Neumar RW. Novel surrogate markers for acute brain damage: cerebrospinal fluid levels corrrelate with severity of ischemic neurodegeneration in the rat. J Cereb Blood Flow Metab. 25:1433-1444. (2005)
55. Pineda, J. A., Lewis, S. B., Valadka, S. B., Papa, L., Hannay, H. J., Heaton, S., Demery, J. A., Liu, M. C., Aikman, J. M., Akle, V., Brophy, G. M., Tepas, J. J., III, Wang, K. K. W., Robertson, C. S. and Hayes, R. L. Clinical significance of αII-spectrin breakdown products in CSF after severe TBI. J. Neurotrauma 24, 354-366. (2007)
56. Mondello, S., Robicsek, S.A., Gabrielli,A., Tepas, J., Robinson, C., Buki, A.,J. Mo, J., Scharf, D., Akinyi, L., Wang, K.K.W., Hayes, R.L. αII-Spectrin Breakdown Products (SBDPs): Diagnosis and Outcome in Severe Traumatic Brain Injury Patients; J. Neurotrauma 27(7):1203-1213. (2010)
57. Zemlan FP, Jauch EC, Mulchahey JJ, Gabbita SP, Rosenberg WS, Speciale SG, Zuccarello M. C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res 947:131-139. (2002)
58. Shaw GJ, Jauch EC, Zemlan FP Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury. Ann Emerg Med 39:254-257. (2002)
59. Dambinova S. A., Khounteev G. A., Izykenova G. A., Zavolokov I. G., Ilyukhina A. Y., Skoromets A. A. Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin. Chem. 49, 1752-1762. (2003)
60. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci. 233:183-198. (2005)
61. Petzold A, Shaw G. Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain. J Immunol Methods. Jan 30;319(1-2):34-40. (2007)
62. Anderson KJ, Scheff SW, Miller KM, Roberts KN, Gilmer LK, Yang C, Shaw G. The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury. J Neurotrauma. Sep;25(9):1079-85. (2008)
63. Liu M.C., Akle, V., Zheng, W.R., Dave, J.R., Tortella, F.C., Hayes, R.L., Wang, K.K.W., Comparing calpain- and caspase-3-degradation patterns in traumatic brain injury by differential proteome analysis. Biochem. J. 394, 715-725. (2006)
64. Yao, C.P., Williams, A.J., Lu, M., Chen, R., Ottens, A.K., Wang, K.K.W., Hayes, R.L., Tortella, F.C. Dave, J. Detection of protein biomarkers using high-throughput immunoblotting following focal ischemic or penetrating ballistic-like brain injuries in rats. Brain Injury, 22 (10): 723-732. (2008)
65. Yao, C., Williams, A.J., Ottens, A.K., Lu, M., Liu, M.C., Hayes, R.L. Wang, K.K.W., Tortella, F.C., Dave, J.R. p43/EMAP-II: a potential biomarker for discriminating traumatic versus ischemic brain injury. J. Neurotrauma. 26(8):1295-305. (2009)
66. Ottens AK, Bustamante L, Golden EC, Yao C, Hayes RL, Wang KKW, Tortella FC, Dave JR. Neuroproteomics: A Biochemical Means to Discriminate the Extent and Modality of Brain Injury. J Neurotrauma. 27(10):1837-52. (2010)
67. Kobeissy, F.H., Larner, S.F., Sadasivan, S., Zhiqun Zheng, Z., Liu, M,.C., Oli, M.W., Robinson, G., Hayes, R.L. and Wang, K.K.W. Neuroproteomic and Systems Biology-Based Discovery of Protein Biomarkers for Traumatic Brain Injury and Clinical Validation (Review). Proteomics - Clinical Applications 2 (10-11): 1467-1483. (2008)
68. Liu MC, Akinyi L, Larner SF, Oli M, Zheng WR, Kobeissy F, Papa L, Lu XC, Dave J, Tortella F, Hayes RL, Wang KKW Ubiquitin-c-terminal hydrolase L1 as a novel biomarker for ischemic and TBI in rats. Euro. J. Neurosci. 31, 722-732. (2010)
69. Svetlov, S.I., Prima, V., Kirk, D.R., Gutierrez, H., Curley, K.C., Hayes, R.L., and Wang, K.K.W. . Morphologic and biochemical characterization of brain injury in a model of controlled blast overpressure exposure. Journal of Trauma 69(4):795-804. (2010)
70. Papa L, Akinyi L, Liu MC, Pineda J, Tepas J, Oli MW, Zheng W, Robinson G, Robicsek SA, Gabrielli A, Heaton S, Hannay J,Demery J, Brophy G, Layon J, Robertson C, Hayes RL & Wang KKW. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe TBI. Critical Care Med, 38, 138-144. (2010)
71. Brophy, G.M.,, Mondello, S., Papa, L,, Robicsek, S., Gabrielli, A., Tepas, J., , Buki, A., Claudia Robertson, C.S., Wang, K.K.W. Hayes, R.L., biokinetic analysis of ubiquitin c-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. J. Neurotrauma 2011 in press.
72. Siman R, Roberts VL, McNeil E, Dang A, Bavaria JE, Ramchandren S, McGarvey M. Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest. Brain Res. 1213:1-11. (2008)
73. Siman R, Toraskar N, Dang A, McNeil E, McGarvey M, Plaum J, Maloney E, Grady MS. A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J Neurotrauma. 26(11):1867-77. (2009)
74. Lewis SB, Wolper R, Chi YY, Miralia L, Wang Y, Yang C, Shaw G.(2010) Identification and preliminary characterization of ubiquitin C terminal hydrolase 1 (UCHL1) as a biomarker of neuronal loss in aneurysmal subarachnoid hemorrhage. J Neurosci Res. May 15;88(7):1475-84 (2010).
75. Allard L, Burkhard PR, Lescuyer P, Burgess JA, Walter N, Hochstrasser DF, Sanchez JC. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin Chem. Nov;51(11):2043-51. Epub 2005 Sep 1. (2005)
76. Brophy, G.M., Pineda, J.A., Pap, L., Lewis, S.B., Valadka, A.B., Hannay, H.J., Heaton, S.C., Demery, J., Liu, M.C., Aikman, J.M., Akle, V., Tepas, J.J. III, Wang, K.K.W., Robertson, C.S., Hayes, R.L. αII-Spectrin Breakdown Product Cerebrospinal Fluid Kinetics Suggest Differences in Cellular Injury Mechanisms after Severe Traumatic Brain Injury. J. Neurotrauma 2009 Apr; 26(4):471-479. (2009)
77. Blyth B, Farahvar A, He H, Nayak A, Yang C, Shaw G, Bazarian JJ. Elevated Serum Ubiquitin Carboxy-terminal Hydrolase L1 is Associated with Abnormal Blood Brain Barrier Function after Traumatic Brain Injury. J Neurotrauma. Mar 23. [Epub ahead of print] (2011)